Although the contribution of TGF-β neutralization to the observed tumor antigen–specific immune activation in our study is unclear, our data indicate that the net effect of TGF-β neutralization with PD-L1 blockade in newly diagnosed HPV-unrelated HNSCC is induction of antitumor immunity. Here, TGFB1 is linked to head and neck squamous cell carcinoma.